Quick Answer
NEOGENOMICS INC reported Net Income Loss of -$108.03 million for the year ending 2025.
- NEOGENOMICS INC showed a decrease of -37.2% in Net Income Loss from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), NEOGENOMICS INC's Net Income Loss has declined by 3,170.5%.
- Historical annual values: Fiscal year 2025: -$108.03 million | Fiscal year 2024: -$78.73 million | Fiscal year 2023: -$87.97 million | Fiscal year 2022: -$144.25 million | Fiscal year 2021: -$8.35 million | Fiscal year 2020: $4.17 million | Fiscal year 2019: $8.01 million | Fiscal year 2018: $2.64 million | Fiscal year 2017: -$396.0 thousand | Fiscal year 2016: -$6.14 million | Fiscal year 2015: -$2.54 million | Fiscal year 2014: $1.13 million | Fiscal year 2013: $2.03 million | Fiscal year 2012: $65.0 thousand | Fiscal year 2011: -$1.18 million | Fiscal year 2010: -$3.30 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: